Integration of QbD risk assessment tools and overall risk management-Reference-Cited by-同舟云学术

Integration of QbD risk assessment tools and overall risk management

Published:2016-09 Issue:5 Volume:44 Page:341-351
ISSN:1045-1056
Container-title:Biologicals
language:en
Short-container-title:Biologicals

Author:

Kelley Brian,Cromwell Mary,Jerkins Joe

Publisher

Elsevier BV

Subject

Pharmacology,General Immunology and Microbiology,Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Reference26 articles.

1. ICH harmonized tripartite guideline, pharmaceutical development;International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use,2009

2. ICH harmonized tripartite guideline, quality risk management;International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use,2005

3. ICH harmonized tripartite guideline, pharmaceutical quality;International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use,2008

4. Considerations for biotechnology product quality by design;Kozlowski,2009

5. Lessons learned from monoclonal antibody applications to the office of biotechnology prodcuts quality by design pilot program;Rellahan,2015

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality by design steered approach for co-encapsulation of timolol maleate and dorzolamide hydrochloride in injectable liposomes;International Journal of Pharmaceutics;2024-10

2. Mastering Quality: Uniting Risk Assessment With Quality by Design (QbD) Principles for Pharmaceutical Excellence;Cureus;2024-08-30

3. QbD-based co-loading of paclitaxel and imatinib mesylate by protamine-coated PLGA nanoparticles effective on breast cancer cells;Nanomedicine;2024-06-27

4. Research progress on the quality control of mRNA vaccines;Expert Review of Vaccines;2024-05-24

5. Utilizing central composite design (CCD) in the optimization of new HPLC-PDA method for the assay of daridorexant: Application to the analysis in bulk and tablet dosage forms;Analytical Chemistry Letters;2024-05-03